(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally...
Stats | |
---|---|
今日成交量 | 25 629.00 |
平均成交量 | 13 216.00 |
市值 | 4.47M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0.850 ( 2022-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.270 |
ATR14 | $0.0230 (0.97%) |
Medigus Ltd. 财务报表
Annual | 2022 |
营收: | $91.86M |
毛利润: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2022 |
营收: | $91.86M |
毛利润: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2021 |
营收: | $10.12M |
毛利润: | $4.80M (47.45 %) |
EPS: | $3.00 |
FY | 2019 |
营收: | $273 000 |
毛利润: | $-182 000 (-66.67 %) |
EPS: | $-54.44 |
Financial Reports:
No articles found.
Medigus Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.850 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.850 | 2022-12-19 |
Last Dividend | $0.850 | 2022-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 2022-12-28 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.850 | -- |
Avg. Dividend % Per Year | 0.87% | -- |
Score | 0.36 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.850 | 5.20% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.135 | 1.500 | -2.70 | -4.05 | [0 - 0.5] |
returnOnAssetsTTM | -0.218 | 1.200 | -7.27 | -8.72 | [0 - 0.3] |
returnOnEquityTTM | -0.527 | 1.500 | -6.97 | -10.00 | [0.1 - 1] |
payoutRatioTTM | -0.269 | -1.000 | -2.69 | 2.69 | [0 - 1] |
currentRatioTTM | 1.297 | 0.800 | 8.51 | 6.81 | [1 - 3] |
quickRatioTTM | 1.221 | 0.800 | 7.52 | 6.02 | [0.8 - 2.5] |
cashRatioTTM | 0.344 | 1.500 | 9.20 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.135 | -1.500 | 7.74 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -4.72 | 1.000 | -2.86 | -2.86 | [3 - 30] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -2.88 | -5.75 | [0 - 20] |
debtEquityRatioTTM | 0.365 | -1.500 | 8.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.150 | 1.000 | -0.833 | -0.833 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0864 | 1.000 | -3.73 | -3.73 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.658 | 1.000 | -4.77 | -4.77 | [0.2 - 2] |
assetTurnoverTTM | 1.616 | 0.800 | 2.56 | 2.05 | [0.5 - 2] |
Total Score | -0.264 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.206 | 1.000 | -0.122 | 0 | [1 - 100] |
returnOnEquityTTM | -0.527 | 2.50 | -4.48 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -1.918 | -5.75 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
payoutRatioTTM | -0.269 | 1.500 | -2.69 | 2.69 | [0 - 1] |
pegRatioTTM | -0.00224 | 1.500 | -3.35 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0551 | 1.000 | -3.88 | 0 | [0.1 - 0.5] |
Total Score | -3.00 |
Medigus Ltd.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。